JP2024503302A5 - - Google Patents

Info

Publication number
JP2024503302A5
JP2024503302A5 JP2023540026A JP2023540026A JP2024503302A5 JP 2024503302 A5 JP2024503302 A5 JP 2024503302A5 JP 2023540026 A JP2023540026 A JP 2023540026A JP 2023540026 A JP2023540026 A JP 2023540026A JP 2024503302 A5 JP2024503302 A5 JP 2024503302A5
Authority
JP
Japan
Prior art keywords
approximately
cationic carrier
carrier unit
item
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023540026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024503302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/062446 external-priority patent/WO2022144811A1/en
Publication of JP2024503302A publication Critical patent/JP2024503302A/ja
Publication of JP2024503302A5 publication Critical patent/JP2024503302A5/ja
Pending legal-status Critical Current

Links

JP2023540026A 2020-12-30 2021-12-29 ミセルナノ粒子及びその使用 Pending JP2024503302A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063199471P 2020-12-30 2020-12-30
US63/199,471 2020-12-30
US202163260782P 2021-08-31 2021-08-31
US63/260,782 2021-08-31
US202163260989P 2021-09-08 2021-09-08
US63/260,989 2021-09-08
PCT/IB2021/062446 WO2022144811A1 (en) 2020-12-30 2021-12-29 Micellar nanoparticles and uses thereof

Publications (2)

Publication Number Publication Date
JP2024503302A JP2024503302A (ja) 2024-01-25
JP2024503302A5 true JP2024503302A5 (cg-RX-API-DMAC7.html) 2025-01-14

Family

ID=82259191

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023540026A Pending JP2024503302A (ja) 2020-12-30 2021-12-29 ミセルナノ粒子及びその使用

Country Status (7)

Country Link
US (1) US20240131048A1 (cg-RX-API-DMAC7.html)
EP (1) EP4271363A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024503302A (cg-RX-API-DMAC7.html)
KR (1) KR20230128298A (cg-RX-API-DMAC7.html)
CA (1) CA3200622A1 (cg-RX-API-DMAC7.html)
TW (1) TW202241460A (cg-RX-API-DMAC7.html)
WO (1) WO2022144811A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022000045A (es) 2019-06-26 2022-04-20 Biorchestra Co Ltd Nanoparticulas micelares y sus usos.
WO2025149946A1 (en) * 2024-01-10 2025-07-17 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1986697B1 (en) * 2006-02-17 2016-06-29 GE Healthcare Dharmacon, Inc. Compositions and methods for inhibiting gene silencing by rna interference
RU2019121801A (ru) * 2016-12-14 2021-01-15 Лигандал, Инк. Композиции и способы для доставки полезной нагрузки в виде нуклеиновой кислоты и/или белка
WO2018139759A1 (ko) * 2017-01-26 2018-08-02 주식회사 바이오오케스트라 마이크로 rna를 이용한 알츠하이머병 진단방법
US11123304B2 (en) * 2017-02-03 2021-09-21 The Brigham And Women's Hospital, Inc. Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles
JP7352958B2 (ja) * 2018-02-01 2023-09-29 国立大学法人 東京大学 核酸送達用ポリマー化合物
CN110156971A (zh) * 2018-02-13 2019-08-23 上海时莱生物技术有限公司 一种两亲性嵌段共聚物及其制备方法和纳米胶束载药系统
WO2019204799A1 (en) * 2018-04-20 2019-10-24 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids
MX2022000045A (es) * 2019-06-26 2022-04-20 Biorchestra Co Ltd Nanoparticulas micelares y sus usos.
KR102304878B1 (ko) * 2019-12-12 2021-09-27 주식회사 바이오오케스트라 miR-485-3p 활성 억제제를 이용한 알츠하이머병 치료 방법
CN111632153B (zh) * 2020-06-23 2023-02-24 宁夏医科大学 一种化学基因药物共载的靶向纳米递药系统及其制备方法
WO2022144812A1 (en) * 2020-12-30 2022-07-07 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof
US20250313835A1 (en) * 2022-07-07 2025-10-09 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof

Similar Documents

Publication Publication Date Title
JP2022538868A5 (cg-RX-API-DMAC7.html)
US12180477B2 (en) Dynamic pharmacokinetic-modifying anchors
Elsabahy et al. Non-viral nucleic acid delivery: key challenges and future directions
JP7627042B2 (ja) O-メチルリッチ完全安定化オリゴヌクレオチド
Liu et al. Dendrimers as non-viral vectors for siRNA delivery
CN102300556B (zh) 含有阴离子药物的药物组合物及其制备方法
Shajari et al. Overcoming the challenges of siRNA delivery: nanoparticle strategies
EP2892505B1 (en) Lipid assemblies comprising anionic lysolipids and use thereof
US20230061751A1 (en) Universal dynamic pharmacokinetic-modifying anchors
JP2019503394A (ja) 分岐オリゴヌクレオチド
CN101970687A (zh) 用于体内基因输送的自组装胶束样纳米颗粒
JP2021525508A (ja) 核酸治療薬のための調節可能な共カップリングポリペプチドナノ粒子送達系の組成物および方法
JP2025106480A5 (cg-RX-API-DMAC7.html)
CN104244987A (zh) 新型寡核苷酸缀合物及其应用
Sarisozen et al. Lipid-based siRNA delivery systems: challenges, promises and solutions along the long journey
JP2022543191A (ja) 増強された生理活性を有する多量体オリゴヌクレオチドの皮下送達
JP2024503303A5 (cg-RX-API-DMAC7.html)
Ita Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides-advances and hurdles
Gurav et al. Antisense oligonucleotides as therapeutics and their delivery
Xu et al. Efficient siRNA delivery using PEG-conjugated PAMAM dendrimers targeting vascular endothelial growth factor in a CoCl2-induced neovascularization model in retinal endothelial cells
tinkaya et al. MicroRNAs and long non-coding RNAs as novel targets in Anti-cancer drug development
Miyata Smart polymeric nanocarriers for small nucleic acid delivery
EP4312977A1 (en) Nucleic acid delivery to the central nervous system
Liu et al. Therapeutic potentials of noncoding RNAs: targeted delivery of ncRNAs in Cancer cells
Fiset et al. Antisense oligonucleotides: problems with use and solutions